Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides.

Waksman G, Kominos D, Robertson SC, Pant N, Baltimore D, Birge RB, Cowburn D, Hanafusa H, Mayer BJ, Overduin M, Resh MD, Rios CB, Silverman L, Kuriyan J.

Nature. 1992 Aug 20;358(6388):646-53.

PMID:
1379696
2.

Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide.

Xu RX, Word JM, Davis DG, Rink MJ, Willard DH Jr, Gampe RT Jr.

Biochemistry. 1995 Feb 21;34(7):2107-21.

PMID:
7532003
3.
4.

Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.

Eck MJ, Shoelson SE, Harrison SC.

Nature. 1993 Mar 4;362(6415):87-91.

PMID:
7680435
5.

The crystal structures of the SH2 domain of p56lck complexed with two phosphonopeptides suggest a gated peptide binding site.

Mikol V, Baumann G, Keller TH, Manning U, Zurini MG.

J Mol Biol. 1995 Feb 17;246(2):344-55.

PMID:
7532720
6.

Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms.

Waksman G, Shoelson SE, Pant N, Cowburn D, Kuriyan J.

Cell. 1993 Mar 12;72(5):779-90.

PMID:
7680960
7.

L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.

Ye B, Akamatsu M, Shoelson SE, Wolf G, Giorgetti-Peraldi S, Yan X, Roller PP, Burke TR Jr.

J Med Chem. 1995 Oct 13;38(21):4270-5.

PMID:
7473554
8.

Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.

Lee CH, Kominos D, Jacques S, Margolis B, Schlessinger J, Shoelson SE, Kuriyan J.

Structure. 1994 May 15;2(5):423-38.

PMID:
7521735
9.

Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.

Karlsson T, Songyang Z, Landgren E, Lavergne C, Di Fiore PP, Anafi M, Pawson T, Cantley LC, Claesson-Welsh L, Welsh M.

Oncogene. 1995 Apr 20;10(8):1475-83.

PMID:
7537362
10.

Conformationally constrained phosphotyrosyl mimetics designed as monomeric Src homology 2 domain inhibitors.

Burke TR Jr, Barchi JJ Jr, George C, Wolf G, Shoelson SE, Yan X.

J Med Chem. 1995 Apr 14;38(8):1386-96.

PMID:
7537333
11.

Direct binding of C-terminal region of p130Cas to SH2 and SH3 domains of Src kinase.

Nakamoto T, Sakai R, Ozawa K, Yazaki Y, Hirai H.

J Biol Chem. 1996 Apr 12;271(15):8959-65.

12.

Structural basis of SH2 domain mutations in X-linked agammaglobulinemia.

Vihinen M, Nilsson L, Smith CI.

Biochem Biophys Res Commun. 1994 Dec 15;205(2):1270-7.

PMID:
7528500
13.

Phosphopeptide occupancy and photoaffinity cross-linking of the v-Src SH2 domain attenuates tyrosine kinase activity.

Garcia P, Shoelson SE, Drew JS, Miller WT.

J Biol Chem. 1994 Dec 2;269(48):30574-9.

PMID:
7527032
14.

Highly conserved eight amino acid sequence in SH2 is important for recognition of phosphotyrosine site.

Hidaka M, Homma Y, Takenawa T.

Biochem Biophys Res Commun. 1991 Nov 14;180(3):1490-7.

PMID:
1719984
15.

Peptide inhibitors of src SH3-SH2-phosphoprotein interactions.

Gilmer T, Rodriguez M, Jordan S, Crosby R, Alligood K, Green M, Kimery M, Wagner C, Kinder D, Charifson P, et al.

J Biol Chem. 1994 Dec 16;269(50):31711-9.

PMID:
7527393
16.
17.

Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.

Hoedemaeker FJ, Siegal G, Roe SM, Driscoll PC, Abrahams JP.

J Mol Biol. 1999 Oct 1;292(4):763-70. Erratum in: J Mol Biol 1999 Dec 3;294(3):825.

PMID:
10525402
18.

Signal transduction. Fishing in Src-infested waters.

Petsko GA.

Nature. 1992 Aug 20;358(6388):625-6. No abstract available.

PMID:
1379695
19.

The three-dimensional solution structure of the SH2 domain from p55blk kinase.

Metzler WJ, Leiting B, Pryor K, Mueller L, Farmer BT 2nd.

Biochemistry. 1996 May 21;35(20):6201-11.

PMID:
8639560
20.

Crystal structure and NMR studies of the apo SH2 domains of ZAP-70: two bikes rather than a tandem.

Folmer RH, Geschwindner S, Xue Y.

Biochemistry. 2002 Dec 3;41(48):14176-84.

PMID:
12450381

Supplemental Content

Support Center